JUN and breast carcinoma: F-6 specifically suppresses JNK-mediated c-Jun activation in K562 leukemic cells but not in MDA MB-231 breast cancer cells (Figure 2 and Figure 3), hence, this lipid could suppress cell proliferation in a cancer-cell type specific manner.